Early diagnosis of bubonic plague using F1 antigen capture ELISA assay and rapid immunogold dipstick

被引:14
作者
Chanteau, S
Rahalison, L
Ratsitorahina, M
Mahafaly
Rasolomaharo, M
Boisier, P
O'Brien, T
Aldrich, J
Keleher, A
Morgan, C
Burans, J
机构
[1] Inst Pasteur, WHO, Collaborating Ctr Plague, Antananarivo, Madagascar
[2] Androva Hosp, Infect Dis Serv, Mahajanga, Madagascar
[3] USN, Med Res Inst, Bethesda, MD 20889 USA
关键词
plague; F1; antigen; diagnosis; dipstick;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Plague is still prevalent in more than 20 countries. Two F1 antigen diagnostic assays tan immuno-capture ELISA and an immunogold chromatography dipstick) were evaluated using bubo aspirates, serum and urine specimens from patients suspected with plague. The specificity of the two F1 assays was found 100 %. Using bacteriology as a gold reference diagnostic assay, 52 patients were Yersinia pestis culture positive and 141 negative. The sensitivity of the F1 ELISA test was 100 % in bubo, 52 % in serum and 58 % in urine specimens. In culture negative patients, the F1 antigen could be found in 10 % bubo aspirates;, 5 % serum and 7 % urine specimens of culture negative patients for whom a seroconversion for anti-F1 antibodies was also observed. The sensitivity of the dipstick assay was 98 % on bubo aspirates specimens. Compared to the ELISA test, tbe agreement rate was 97.5 % and the correlation coefficient tau = 0.90 (p < 10(-3)). In conclusion, the diagnosis of bubonic plague has to be performed on bubo fluid rather than on serum or urine specimens. Both the F1 ELISA and the dipstick assays are valuable tools for an early diagnosis and for the surveillance of plague.
引用
收藏
页码:279 / 283
页数:5
相关论文
共 17 条
[1]  
BAKER EE, 1952, J IMMUNOL, V68, P131
[2]   Urban epidemic of bubonic plague in Majunga, Madagascar: Epidemiological aspects [J].
Boisier, P ;
Rasolomaharo, M ;
Ranaivoson, G ;
Rasoamanana, B ;
Rakoto, L ;
Andrianirina, Z ;
Andriamahefazafy, B ;
Chanteau, S .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1997, 2 (05) :422-427
[3]  
BRUBAKER R R, 1970, Infection and Immunity, V1, P446
[4]  
Cavanaugh D C, 1979, Bull Pan Am Health Organ, V13, P399
[5]   F1 antigenaemia in bubonic plague patients, a marker of gravity and efficacy of therapy [J].
Chanteau, S ;
Rabarijaona, L ;
O'Brien, T ;
Rahalison, L ;
Hager, J ;
Boisier, P ;
Burans, J ;
Rasolomaharo, M .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1998, 92 (05) :572-573
[6]  
CHANTEAU S, 2000, MICROB INFECT, V1, P1
[7]  
CHEN TH, 1966, B WORLD HEALTH ORGAN, V34, P911
[8]  
Rahalison L, 2000, J CLIN MICROBIOL, V38, P260
[9]   Field evaluation of an immunoglobulin G anti-F1 enzyme-linked immunosorbent assay for serodiagnosis of human plague in Madagascar [J].
Rasoamanana, B ;
Leroy, F ;
Boisier, P ;
Rasolomaharo, M ;
Buchy, P ;
Carniel, E ;
Chanteau, S .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (05) :587-591
[10]   Comparison of Yersinia CIN agar and mouse inoculation assay for the diagnosis of plague [J].
Rasoamanana, B ;
Rahalison, L ;
Raharimanana, C ;
Chanteau, S .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1996, 90 (06) :651-651